Pharmaceuticals
Philippines Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Analysis
The Philippines Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics market is expected to grow from $8 Mn in 2022 to $18 Mn in 2030 with a CAGR of 10.70% for the year 2022-30. As more domestic and global businesses invest in the creation and marketing of PNH medicines, there has been an increase in interest in the Philippine healthcare sector. The market may be stimulated by this investment to innovate and compete, giving patients more options for therapy. The market is segmented by therapy, diagnostic test, by distribution channels. Some key players in this market include Pascual Laboratories, Pharex HealthCorp, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Akari Therapeutics, Amgen, CSL Behring and Bioverativ.
Buy Now
Philippines Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Executive Analysis
The Philippines Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics market size is at around $8 Mn in 2022 and is projected to reach $18 Mn in 2030, exhibiting a CAGR of 10.70% during the forecast period. The Philippines' current health expenditure increased from $16.12 billion in 2020 to $19.689 billion in 2023. Consequently, at the current rate of exchange, made up 5.6% of the GDP. In the Philippines, the household out-of-pocket contribution accounted for 40.865 per cent of current health expenditures in 2023.
In the Philippines, there are 1.63 cases of paroxysmal nocturnal hemoglobinuria per million people. This is based on an analysis of 4,905 patients with diverse hematologic illnesses from four major hospitals in the Philippines, which found 8 confirmed cases of PNH. A rare blood condition known as paroxysmal nocturnal hemoglobinuria that affects red blood cells can cause a number of symptoms, such as weariness, shortness of breath, and blood clots. The Philippine General Hospital, St. Luke's Medical Centre, and the Makati Medical Centre are just a few of the hospitals and medical facilities in the country that provide PNH diagnosis and care. Blood transfusions, anticoagulant therapy, and bone marrow transplants are some PNH treatment options in the Philippines. Depending on the institution and the circumstances of each patient, the accessibility and cost of various therapies may change.
-therapeutics-market-analysis.png)
Market Dynamics
Market Growth Drivers
As more domestic and global businesses invest in the creation and marketing of PNH medicines, there has been an increase in interest in the Philippine healthcare sector. The market may be stimulated by this investment to innovate and compete, giving patients more options for therapy. The market for PNH medicines may rise as PNH diagnosis rates rise as healthcare professionals and patients in the Philippines become more aware of the condition. A rising healthcare budget in the Philippines might make more money available for PNH medicines research and development, as well as more therapy alternatives for patients. The Philippine government has been working to enhance the nation's healthcare system, and one of their initiatives has been the adoption of laws that encourage the creation and accessibility of novel treatments.
Market Restraints
In the Philippines, a large number of patients lack access to healthcare coverage or may have limited coverage, which may restrict their ability to receive PNH therapy. The availability and prioritisation of PNH treatment options may be constrained by the healthcare system in the Philippines's competing priorities and limited resources. It's possible that many patients and medical staff in the Philippines are unaware of PNH and its available treatments, which could result in a delayed or ineffective diagnosis and course of action.
Competitive Landscape
Key Players
- Pascual Laboratories (PH)
- Pharex HealthCorp (PH)
- Getz Healthcare (PH)
- Alexion Pharmaceuticals
- Alnylam Pharmaceuticals
- Akari Therapeutics
- Amgen
- CSL Behring
- Bioverativ
Healthcare Policies and Regulatory Landscape
The Philippine Food and Drug Administration (FDA) is the regulatory organisation in charge of overseeing pharmaceutical products in the country. Food, pharmaceuticals, and other health-related products must be produced, imported, exported, distributed, and sold under FDA regulation and supervision. The FDA guarantees the quality, efficacy, and safety of these products. In terms of healthcare policies, the Philippine government has put in place a number of programmes to increase citizens' access to healthcare services. The Universal Health Care Law, which was signed in 2019, is one of these initiatives. All Filipinos will now have access to high-quality, reasonably priced healthcare services thanks to this law. All Filipinos are required by this law to join the Philippine Health Insurance Corporation (PhilHealth), and they all have access to a wide range of medical benefits and services. The Philippine government has also started a number of initiatives to deal with uncommon conditions, such as Paroxysmal Nocturnal Hemoglobinuria (PNH). To learn more about PNH's incidence and prevalence across the nation, the Department of Health has added it to its National Rare Disease Registry. In order to help people with rare disorders like PNH who need expensive therapies, the government also established the Rare Disease Fund.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
Philippines Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics Market Segmentation
By Therapy
- Medication Therapy
- Stem Cell Therapy
- Blood Transfusion Therapy
By Diagnostic Tests
- CBC
- LHD
- Bone Marrow Examination
- Flow Cytometry
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Methodology for Database Creation
Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.
Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.
How Do We Get It?
Our database is created and maintained through a combination of secondary and primary research methodologies.
1. Secondary Research
With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:
- Analyzing historical proprietary data collected from multiple projects.
- Regularly updating our existing data sets with new findings and trends.
- Ensuring data consistency and accuracy through rigorous validation processes.
With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:
- Searching through academic conferences, published research, citations, and social media platforms
- Collecting and compiling diverse data to build a comprehensive and detailed database
- Continuously updating our database with new information to ensure its relevance and accuracy
2. Primary Research
To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:
- Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
- Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
- Continuously refreshing our database to ensure that the information remains current and reliable.
- Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.
Combining Secondary and Primary Research
By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:
- Merging historical data from secondary research with real-time data from primary research.
- Conducting thorough data validation and cleansing to remove inconsistencies and errors.
- Organizing data into a structured format that is easily accessible and usable for various applications.
- Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.
Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.
To request a free sample copy of this report, please complete the form below.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
Related reports (by category)
Pharmaceuticals
Spain Medical Cannabis Drugs Market Analysis
Pharmaceuticals
Germany Medical Imaging Market Analysis
Pharmaceuticals
US Acute Lymphocytic Leukemia (ALL) Therapeutics Market Analysis
Related reports (by geography)
Pharmaceuticals
Philippines Infectious Disease Drugs Market Analysis
Pharmaceuticals
Philippines Biosimilars Market Analysis
Medical Devices
